Cargando…
Risk of congenital anomalies in pregnant users of statin drugs
AIMS: Evidence from animal studies suggests that statin medications should not be taken during pregnancy. Our aim was to examine the association between the use of statins in early pregnancy and the incidence of congenital anomalies. METHODS: A population-based pregnancy registry was built. Three st...
Autores principales: | Ofori, Benjamin, Rey, Evelyne, Bérard, Anick |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2048566/ https://www.ncbi.nlm.nih.gov/pubmed/17506782 http://dx.doi.org/10.1111/j.1365-2125.2007.02905.x |
Ejemplares similares
-
Evaluation of the immunogenicity of the dabigatran reversal agent idarucizumab during Phase I studies
por: Norris, Stephen, et al.
Publicado: (2017) -
First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials
por: Moehrle, Joerg J, et al.
Publicado: (2013) -
Assessing the safety features of electronic patient medication record systems used in community pharmacies in England
por: Ojeleye, Oluwagbemileke, et al.
Publicado: (2014) -
Severity of the TGN1412 trial disaster cytokine storm correlated with IL-2 release
por: Eastwood, David, et al.
Publicado: (2013) -
High dose droperidol and QT prolongation: analysis of continuous 12-lead recordings
por: Calver, Leonie, et al.
Publicado: (2014)